Clinical-stage biotech Coave Therapeutics focused on treatments for diseases of the eyes and central nervous system (CNS) is combining its expertise with that of contract development and manufacturing organisation ABL, a specialist in viruses for vaccine candidates, gene and cancer therapies, to co-develop manufacturing technologies for AAV-based gene therapy products. Click to read more...